Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)
Go back to Oppenheimer Keeps Summit Therapeutics (SMMT) at 'Outperform' Amid New DMD Deal (SRPT)| Stratcomm Media, Ltd. (NASDAQ: SMMT) | Delayed: 12.39 -0.72 (5.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.11 | 52 Week High | $19.75 | |||
| Open | $13.01 | 52 Week Low | $4.26 | |||
| Day High | $13.02 | P/E | N/A | |||
| Day Low | $12.36 | EPS | $0.00 | |||
| Volume | 2,224,975 | |||||
| SAREPTA THERAP (NASDAQ: SRPT) | Delayed: 18.80 -0.93 (4.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.73 | 52 Week High | $63.73 | |||
| Open | $19.42 | 52 Week Low | $8.00 | |||
| Day High | $19.95 | P/E | N/A | |||
| Day Low | $18.59 | EPS | $-5.69 | |||
| Volume | 675,236 | |||||
